Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Cerebral Infarction, Right Hemisphere
0.300 Biomarker phenotype CTD_human The application of fast multiparametric protocol MRI-based thrombolysis with rt-PA hyperacute cerebral infarction. 18544249 2008
Cerebral Infarction, Right Hemisphere
0.300 Therapeutic phenotype CTD_human The application of fast multiparametric protocol MRI-based thrombolysis with rt-PA hyperacute cerebral infarction. 18544249 2008
Cerebral Infarction, Right Hemisphere
0.300 Therapeutic phenotype CTD_human Homonymous hemianopia caused by occipital lobe infarction in heparin-induced thrombocytopenia and thrombosis syndrome. 16148626 2005
Cerebral Infarction, Right Hemisphere
0.300 Biomarker phenotype CTD_human Homonymous hemianopia caused by occipital lobe infarction in heparin-induced thrombocytopenia and thrombosis syndrome. 16148626 2005
Cerebral Infarction, Right Hemisphere
0.300 Biomarker phenotype CTD_human Sequential combination of intravenous recombinant tissue plasminogen activator and intra-arterial urokinase in acute ischemic stroke. 15502123 2004
Cerebral Infarction, Right Hemisphere
0.300 Therapeutic phenotype CTD_human Sequential combination of intravenous recombinant tissue plasminogen activator and intra-arterial urokinase in acute ischemic stroke. 15502123 2004
Cerebral Infarction, Right Hemisphere
0.300 Biomarker phenotype CTD_human Ischemic cerebral infarction after rt-PA and heparin therapy for acute myocardial infarction. The TIMI-II pilot and randomized clinical trial combined experience. 9183334 1997
Cerebral Infarction, Right Hemisphere
0.300 Therapeutic phenotype CTD_human Ischemic cerebral infarction after rt-PA and heparin therapy for acute myocardial infarction. The TIMI-II pilot and randomized clinical trial combined experience. 9183334 1997
Cerebral Infarction, Right Hemisphere
0.300 Therapeutic phenotype CTD_human Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery stroke. 1579960 1992
Cerebral Infarction, Right Hemisphere
0.300 Biomarker phenotype CTD_human Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery stroke. 1579960 1992
Cerebral Infarction, Right Hemisphere
0.300 Biomarker phenotype CTD_human Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical trial. 1899364 1991
Cerebral Infarction, Right Hemisphere
0.300 Therapeutic phenotype CTD_human Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical trial. 1899364 1991